142 related articles for article (PubMed ID: 37941559)
1. Case Report: Serum methotrexate monitoring by immunoassay: confusion by by-product, confusion by antidote.
Sharma A; Benoit P; Lansigan F; Nierenberg D
Front Oncol; 2023; 13():1237178. PubMed ID: 37941559
[TBL] [Abstract][Full Text] [Related]
2. Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.
Widemann BC; Balis FM; Kim A; Boron M; Jayaprakash N; Shalabi A; O'Brien M; Eby M; Cole DE; Murphy RF; Fox E; Ivy P; Adamson PC
J Clin Oncol; 2010 Sep; 28(25):3979-86. PubMed ID: 20679598
[TBL] [Abstract][Full Text] [Related]
3. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
Matherly LH; Barlowe CK; Goldman ID
Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.
Ghannoum M; Roberts DM; Goldfarb DS; Heldrup J; Anseeuw K; Galvao TF; Nolin TD; Hoffman RS; Lavergne V; Meyers P; Gosselin S; Botnaru T; Mardini K; Wood DM;
Clin J Am Soc Nephrol; 2022 Apr; 17(4):602-622. PubMed ID: 35236714
[TBL] [Abstract][Full Text] [Related]
5. Predictions of a network thermodynamics computer model relating to the mechanism of methotrexate rescue by 5-formyltetrahydrofolate and to the importance of inhibition of thymidylate synthase by methotrexate-polyglutamates.
White JC
Adv Exp Med Biol; 1983; 163():305-26. PubMed ID: 6193692
[TBL] [Abstract][Full Text] [Related]
6. Glucarpidase to combat toxic levels of methotrexate in patients.
Green JM
Ther Clin Risk Manag; 2012; 8():403-13. PubMed ID: 23209370
[TBL] [Abstract][Full Text] [Related]
7. Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available.
Rosales A; Madrid A; Muñoz M; Dapena JL; Ariceta G
Front Pediatr; 2021; 9():635152. PubMed ID: 34490152
[No Abstract] [Full Text] [Related]
8. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
Goldman ID; Matherly LH
NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
[TBL] [Abstract][Full Text] [Related]
9. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
[TBL] [Abstract][Full Text] [Related]
10. Pediatric case of accidental oral overdose of methotrexate.
Gibbon BN; Manthey DE
Ann Emerg Med; 1999 Jul; 34(1):98-100. PubMed ID: 10382002
[TBL] [Abstract][Full Text] [Related]
11. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7).
Allegra CJ; Boarman D
Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762
[TBL] [Abstract][Full Text] [Related]
12. Glucarpidase for the management of elevated methotrexate levels in patients with impaired renal function.
Fermiano M; Bergsbaken J; Kolesar JM
Am J Health Syst Pharm; 2014 May; 71(10):793-8. PubMed ID: 24780487
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity - a randomized controlled trial.
Bhargava M; Kopp CR; Naidu S; Dhibar DP; Saroch A; Khadwal A; Narang T; Jain S; Khullar A; Leishangthem B; Sharma A; Kumar S; Sharma S; Jain S; Dhir V
Arthritis Res Ther; 2023 May; 25(1):82. PubMed ID: 37208770
[TBL] [Abstract][Full Text] [Related]
14. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
Matherly LH; Fry DW; Goldman ID
Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
[TBL] [Abstract][Full Text] [Related]
15. Glucarpidase Intervention for Delayed Methotrexate Clearance.
Cavone JL; Yang D; Wang A
Ann Pharmacother; 2014 Jul; 48(7):897-907. PubMed ID: 24742398
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of leucovorin reversal of methotrexate cytotoxicity in human MCF-7 breast cancer cells.
Boarman DM; Baram J; Allegra CJ
Biochem Pharmacol; 1990 Dec; 40(12):2651-60. PubMed ID: 2260989
[TBL] [Abstract][Full Text] [Related]
17. Amelioration by leucovorin of methotrexate developmental toxicity in rabbits.
DeSesso JM; Goeringer GC
Teratology; 1991 Mar; 43(3):201-15. PubMed ID: 2014483
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacologic rationale for high-dose methotrexate.
Jolivet J
NCI Monogr; 1987; (5):61-5. PubMed ID: 2448656
[TBL] [Abstract][Full Text] [Related]
19. Dihydrofolate-mediated reversal of methotrexate toxicity to hepatoma cells in vitro.
Kruger-McDermott C; Balinska M; Galivan J
Cancer Lett; 1986 Jan; 30(1):79-84. PubMed ID: 3484673
[TBL] [Abstract][Full Text] [Related]
20. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
Chello PL; McQueen CA; DeAngelis LM; Bertino JR
Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
